Good news, but I still avoid
Mediclinic saw some good news out of Abu Dhabi as the 20% co-payment for certain medical aid users was waived at Mediclinic hospitals. The share shot up 13.3% on the news and this prompted many readers to point out to me that not all regulatory news is bad news in the health sector, and indeed they are right. However, my view remains that most regulatory news will be bad in this space, and more importantly, I do not want an investment that is beholden to regulatory news. So, I continue to stay away from this sector.